The development of methods for obtaining monoclonal antibody-producing cells

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Monoclonal antibodies (mAbs) are biomolecules of great scientific and practical significance. In contrast to polyclonal antibodies from immune sera, they are homogeneous and monospecific, since they are produced by hybridoma cells representing a clone arising from a single cell. The successful technology was described for the first time in 1975; the inventors were later awarded the Nobel Prize. Currently, mAbs are broadly used as a research tool, in diagnostics and medicine in particular for the treatment of cancer or in transplantology. About 47 therapeutics based on monoclonal antibodies are now available in the US and Europe, and the number is still growing. Production of monoclonal antibodies is a multistage, time-consuming and costly process. Growing demand for these molecules creates space for research focused on improvements in hybridoma technology. Lower costs, human labor, and time are important goals of these attempts. In this article, a brief review of current methods and their advances is given.

Authors and Affiliations

Michał Skowicki, Tomasz Lipiński

Keywords

Related Articles

Preliminary study on application of urine amino acids profiling for monitoring of renal tubular injury using GLC-MS

The early diagnosis of the nephrotoxic effect of xenobiotics and drugs is still an unsolved problem. Recent studies suggest a correlation between the nephrotoxic activity of xenobiotics and increased concentration of ami...

Effects of lactoferrin on elicitation of the antigen-specific cellular and humoral cutaneous response in mice

Immune contact dermatitis is an inflammation of the skin resulting from exposure to allergens in the environment. The aim of this study was to compare the actions of lactoferrin (LF), a natural immunomodulator, on the el...

Znaczenie fosfofruktokinazy II (PFK-2)/fruktozo-2,6-bisfosfatazy (FBPazy-2) w przeprogramowaniu metabolicznym komórek nowotworowych

Utrzymanie dużej aktywności glikolitycznej w komórkach nowotworowych jest konieczne do zapewnienia odpowiedniego poziomu energii oraz składników budulcowych dla intensywnie proliferujących komórek. Na uwagę zasługuje to,...

The application of cell cultures, body fluids and tissues in oncoproteomics

Mass spectrometry (MS)-based proteomics is a rapidly developing technology for the large scale analysis of proteins, their interactions and subcellular localization. In recent years proteomics has attracted much attentio...

Download PDF file
  • EP ID EP220660
  • DOI -
  • Views 190
  • Downloads 0

How To Cite

Michał Skowicki, Tomasz Lipiński (2016). The development of methods for obtaining monoclonal antibody-producing cells. Advances in Hygiene and Experimental Medicine, 70(), 367-379. https://europub.co.uk/articles/-A-220660